Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Santyl in diabetic foot ulcers
NCT02111291Phase 4Completed
- Sponsor
- Healthpoint Biotherapeutics
- Start
- Apr 2014
- Primary completion
- Dec 2015
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of collagenase clostridium histolyticum in diabetic foot ulcer (DFU), sponsored by Healthpoint Biotherapeutics. Started Apr 2014; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02111291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111291.